Chris O’Donnell

Chris O’Donnell

Company: Novartis Institutes of Biomedical Research

Job title: Global Head CVM


Opportunities & Challenges for Genomics to Enhance Biomarker- Guided Treatment Strategies in Prevention & Treatment of Cardiometabolic Disease 11:00 am

Determining ways to identify patients who would benefit from genetically oriented approaches such as siRNA, ASO and longer-term genome editing How do we ensure we’re treating patients early enough to improve their course of life? Ideal screening method: cascade, paediatric or population?Read more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.